Market Cap 17.24B
Revenue (ttm) 4.31B
Net Income (ttm) 467.68M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 10.86%
Debt to Equity Ratio 0.12
Volume 100
Avg Vol 946
Day's Range N/A - N/A
Shares Out 118.36M
Stochastic %K 100%
Beta 0.74
Analysts Strong Sell
Price Target N/A

Company Profile

bioMérieux S.A. develops and markets in vitro diagnostic solutions for infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers CHROMID RANGE, a chromogen culture media; RAPIDEC CARBA NP biochemical test for the detection of carbapenemase producing bacteria; air, surface, and water monitoring systems; BACT/ALERT VIRTUO or 3D, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system; BIOFIRE SPOTFIRE Lowplex PCR point-of-car...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 33 4 78 87 20 00
Fax: 33 4 78 87 20 90
Address:
376 Chemin De l’Orme, Marcy-l'Étoile, France
Latest News on BMXMF
No data available.